Products/Pipelines
One of Dyax's key priorities is the expansion of our internal pipeline of drug candidates. Utilizing our patented drug discovery technology, phage display, we have built an innovative pipeline focused on finding therapies for unmet medical needs. This pipeline includes our lead drug candidate, DX-88 (ecallantide), and several active programs in discovery and preclinical development.
We also give other companies access to our technology with various types of licenses and collaborations under our Licensing and Funded Research Program (LFRP). The LFRP licensee pipeline includes one approved product and numerous drug candidates in clinical development.